Genendo Loses Drug Importation Appeal

Law360, New York (May 11, 2007, 12:00 AM EDT) -- The Food and Drug Administration had its power to regulate imported drugs clarified Thursday when the Seventh Circuit Court of Appeals upheld its 2003 seizure and condemnation of drugs, imported by Genendo Pharmaceuticals, that were improperly packaged and labeled.

The drugs in question included over 100 boxes of Lipitor, an anti-cholesterol drug manufactured by Pfizer Inc., as well as almost 25,000 tablets of Zocor, another anti-cholesterol drug, manufactured by Merck & Co.

Under the Federal Food, Drug, and Cosmetic Act, all imported drugs must comply with...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.